Novateor Research Laboratories Ltd - 542771 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jaysukhlal Shantilal Doshi & PACs Novateor Research Laboratories Ltd - 542771 - PCS Certificate For Transfer/Transmission/Transposition Under Reg. 40(10)
PCS certificate for Transfer/Transmission/Transposition under Reg. 40(10) for the period of 01.04.2021 to 31.03.2022 Novateor Research Laboratories Ltd - 542771 - Adoption Of Financial Results For The Half Year And Year Ended On 31.03.2022
Pursuant to Regulation 30, 33 and any other Regulation of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 that a meeting of the Board of Directors of the Company was held on Monday, 30th May, 2022 at Registered office of the company, In that meeting the Board has decided the following matters: 1. Audited financial results (Standalone) of the Company for the half year and financial year ended on March 31, 2022. Pursuant to Regulation 30 & 33 of the Listing Regulations, please find the enclosed the following: I. Audited Financial Results with cash flow statement (Standalone) for the half year and year ended on March 31, 2022. II. Audit Report in respect of the aforesaid Results. III. Declaration Pursuant to Regulation 33 (3) (d) of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) (Amendment) Regulations. 2016. The Board Meeting commenced at 6:00 P.M. and concluded at 7:45 P.M. Novateor Research Laboratories Ltd - 542771 - Board Meeting Outcome for Outcome Of Board Meeting Was Held On Monday, 30Th May, 2022 At Registered Office Of The Company
Pursuant to Regulation 30, 33 and any other Regulation of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 that a meeting of the Board of Directors of the Company was held on Monday, 30th May, 2022 at Registered office of the company, In that meeting the Board has decided the following matters: 1. Audited financial results (Standalone) of the Company for the half year and financial year ended on March 31, 2022. Pursuant to Regulation 30 & 33 of the Listing Regulations, please find the enclosed the following: I. Audited Financial Results with cash flow statement (Standalone) for the half year and year ended on March 31, 2022. II. Audit Report in respect of the aforesaid Results. III. Declaration Pursuant to Regulation 33 (3) (d) of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) (Amendment) Regulations. 2016. The Board Meeting commenced at 6:00 P.M. and concluded at 7:45 P.M. Novateor Research Laboratories Ltd - 542771 - Board Meeting Intimation for Adoption Of Half Yearly And Yearly Audited Financial Statement As On March 31, 2022
Novateor Research Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 ,inter alia, to consider and approve 1. To consider, approve and take on record the audited financial results of the company for the half year and year ended March 31, 2022; 2. To consider, approve and take on record the audited financial statements of the company for the year ended March 31, 2022. 3. To transact any other matter with prior approval of chairman. Novateor Research Laboratories Ltd - 542771 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Novateor Research Laboratories Ltd 2 CIN NO. L24230GJ2011PLC064731 3 Report filed for FY 2021-2022 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* FY 2020-21, 2021-22 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) 0 8Quantum of (d), which has been met from (c)(e)* 0 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* 0 Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)FY 2020-21, 2021-22 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-Poonam Pravinbhai PanchalDesignation :-Company Secretary and Compliance Officer Name of the Chief Financial Officer :- Navdeep Mehta Designation : -Chief Financial Officer Date: 10/05/2022 Novateor Research Laboratories Ltd - 542771 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayNovateor Research Laboratories Ltd 2CINL24230GJ2011PLC064731 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Poonam Pravinbhai Panchal Designation: Company Secretary Compliance officer EmailId: [email protected] Name of the Chief Financial Officer: Navdeep Mehta Designation: Chief Financial Officer EmailId: [email protected] Date: 28/04/2022 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. Novateor Research Laboratories Ltd - 542771 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jaysukhlal Shantilal Doshi & PACs Novateor Research Laboratories Ltd - 542771 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jaysukhlal Shantilal Doshi & PACs Novateor Research Laboratories Ltd - 542771 - Compliance Certificate Under Reg. 7 (3) Of SEBI (LODR) Regulations, 2015
Compliance Certificate under Reg. 7 (3) of SEBI (LODR) Regulations, 2015 for the half year ended on 31st March, 2022